Skip to main content

Table 3 Non-responder analysis: Descriptive results and prevalence of atopic diseases, data taken from ISAAC Phase Two.

From: Study on Occupational Allergy Risks (SOLAR II) in Germany: Design and methods

%
95% CI1
Group 12
(n = 2581)
Group 23
(n = 1767)
Group 34
(n = 2051)
Female 55.0
53.1; 56.9
53.8
51.5; 56.1
58.1
56.0; 60.3
High parental level of education5 41.5
39.5; 43.5
47.1
44.7; 49.4
58.9
56.7; 61.0
Smoking during pregnancy 13.5
11.9; 15.1
9.8
8.3; 11.4
5.9
4.8; 7.0
Passive smoke exposure 50.3
48.3; 52.4
47.3
44.9; 49.7
36.4
34.3; 38.5
Current wheeze6 6.9
5.9; 7.9
9.5
8.1; 10.8
8.2
7.0; 9.4
Doctor diagnosed asthma 3.3
2.6; 4.0
4.5
3.5; 5.5
3.4
2.6; 4.2
Current allergic rhinitis7 11.1
9.8; 12.3
14.1
12.4; 15.7
14.4
12.8; 15.9
Current atopic dermatitis8 11.6
10.4; 12.9
13.2
11.6; 14.8
15.2
13.6; 16.7
Specific IgE > 0.7 kU/L 28.7
26.0; 31.3
34.8
32.1; 37.4
33.4
31.0; 35.7
Positive skin prick test 23.2
21.0; 25.5
24.5
22.3; 26.7
23.6
21.7; 25.6
Bronchial hyperreactivity 14.7
11.9; 17.4
19.5
16.5; 22.4
17.3
14.8; 19.8
Parental allergic disease9 36.2
34.3; 38.1
40.9
38.6; 43.3
46.2
44.0; 48.3
  1. 1 95% CI: 95% Confidence Interval
  2. 2 group 1: people who participated only in ISAAC Phase Two
  3. 3 group 2: people who participated in ISAAC Phase Two and SOLAR I
  4. 4 group 3: people who participated in SOLAR II (without the people of group 1 and 2)
  5. 5 at least one parent with a minimum of 12 years of education
  6. 6 wheezing in the last 12 months
  7. 7 problems with sneezing or a runny or blocked nose (without having a cold) accompanied by itchy-
  8. watery eyes in the last 12 months
  9. 8 itching eczema in the last 12 months persisting at least 6 months
  10. 9 asthma, allergic rhinitis or atopic dermatitis
  11. bold: statistically significant differences between groups